Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method.
Adam CukerJenny M DespotovicRachael F GraceCaroline KruseMichele P LambertHoward A LiebmanRoger M LyonsKeith R McCraeVinod PullarkatJeffrey S WasserDavid BeenhouwerSarah N GibbsIrina YermilovMichael S BroderPublished in: Research and practice in thrombosis and haemostasis (2020)
This guidance could support clinical decision making and the development of clinical trials that prospectively test the safety of tapering TPO-RAs.